DK0894500T3 - Streptococcus equi-vaccine - Google Patents

Streptococcus equi-vaccine

Info

Publication number
DK0894500T3
DK0894500T3 DK98202512T DK98202512T DK0894500T3 DK 0894500 T3 DK0894500 T3 DK 0894500T3 DK 98202512 T DK98202512 T DK 98202512T DK 98202512 T DK98202512 T DK 98202512T DK 0894500 T3 DK0894500 T3 DK 0894500T3
Authority
DK
Denmark
Prior art keywords
streptococcus equi
equi vaccine
vaccine
vaccines
manufacture
Prior art date
Application number
DK98202512T
Other languages
English (en)
Inventor
Antonius Arnoldus Chris Jacobs
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32669079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0894500(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0894500T3 publication Critical patent/DK0894500T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98202512T 1997-07-29 1998-07-27 Streptococcus equi-vaccine DK0894500T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202365 1997-07-29
EP98202512A EP0894500B1 (en) 1997-07-29 1998-07-27 Streptococcus equi vaccine

Publications (1)

Publication Number Publication Date
DK0894500T3 true DK0894500T3 (da) 2004-11-15

Family

ID=32669079

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98202512T DK0894500T3 (da) 1997-07-29 1998-07-27 Streptococcus equi-vaccine

Country Status (10)

Country Link
US (1) US6120775A (da)
EP (1) EP0894500B1 (da)
JP (1) JP4563520B2 (da)
AT (1) ATE270112T1 (da)
CA (1) CA2243730C (da)
DE (1) DE69824794T2 (da)
DK (1) DK0894500T3 (da)
ES (1) ES2224331T3 (da)
HU (1) HU223762B1 (da)
PT (1) PT894500E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682745B1 (en) 1998-07-28 2004-01-27 Christiaan Antonius Arnoldus Jacobs Use of bacterium for manufacture of a vaccine
ATE257713T1 (de) * 1999-01-26 2004-01-15 Akzo Nobel Nv Verwendung lebender abgeschwächter bakterien zur herstellung eines submukosalen impstoffes
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
WO2007126885A2 (en) * 2006-03-28 2007-11-08 The Trustees Of The University Of Pennsylvania Live, attenuated pneumococcal vaccine
US7455844B2 (en) * 2006-03-29 2008-11-25 Merial Limited Vaccine against streptococci
AU2008336295B2 (en) 2007-12-13 2013-07-11 Intervacc Ab Improved immunizing composition
EA029938B1 (ru) * 2015-04-09 2018-05-31 Тоо "Акынтай" Вакцина против мыта лошадей

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
DE3263103D1 (en) * 1981-06-19 1985-05-23 Secr Social Service Brit Protection against dental caries
AR241545A1 (es) * 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US4788059A (en) * 1985-07-15 1988-11-29 Coopers Animal Health, Inc. Equine strangles vaccine and the method of preparing and using the same
IL86583A0 (en) * 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
AU637969B2 (en) * 1987-10-07 1993-06-17 Washington University A method of maintaining a desired recombinant gene in a genetic population of cells
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.

Also Published As

Publication number Publication date
HU9801705D0 (en) 1998-09-28
HUP9801705A3 (en) 2001-11-28
CA2243730A1 (en) 1999-01-29
HU223762B1 (hu) 2005-01-28
ATE270112T1 (de) 2004-07-15
PT894500E (pt) 2004-10-29
US6120775A (en) 2000-09-19
HUP9801705A2 (hu) 1999-05-28
EP0894500A1 (en) 1999-02-03
ES2224331T3 (es) 2005-03-01
DE69824794T2 (de) 2004-11-25
EP0894500B1 (en) 2004-06-30
CA2243730C (en) 2009-12-22
DE69824794D1 (de) 2004-08-05
JP4563520B2 (ja) 2010-10-13
JPH11100329A (ja) 1999-04-13

Similar Documents

Publication Publication Date Title
EP1499191A4 (en) REGULATED ATTENUATION OF LIVE VACCINATES TO IMPROVE THE CROSS IMMUNE PROTECTION FUNCTION
PT865297E (pt) Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
CY2009014I1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
DK0563265T3 (da) Orale præparater
NL300331I1 (nl) Kweken van lawsonia intracellularis, vaccins tegenlawsonia
DK0585681T3 (da) Anvendelse af IL-4-receptoren til behandling, forebyggelse og diagnose af infektionssygdomme
BRPI9912663B1 (pt) vacina contra cáncer e polipeptìdeo.
HUP0203056A1 (hu) Vakcinakészítmény
CY1107550T1 (el) Συνδυαστικα εμβολια μηνιγγιτιδας b/c
BRPI9700768B8 (pt) vacina viva para combater infecção por streptococcus em cavalos.
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DZ2283A1 (fr) Composition de vaccin.
DK0939648T3 (da) Rotavirusvaccineformuleringer
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
WO2002010343A3 (en) Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
DE69824794D1 (de) Streptococcus equi Impfstoff
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK1109574T3 (da) Vaccine mod seksuelt overförte sygdomme
ATE249740T1 (de) Orale antimikrobielle und desodoriende zusammensetzungen
ES2136064T3 (es) Vacunas de toxoide de pasteurella multocida.
FR2661809B3 (fr) Diffuseur personnel de parfum ou de desodorisant.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
EP0931082A4 (en) Nodulisporic acid derivatives
MX9202293A (es) Composicion de vacuna no-irritante.